Lung Disease Therapeutic Drug - Global and China Top Players Market Share and Ranking 2023
According to Latest Research, the global market for Lung Disease Therapeutic Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Lung Disease Therapeutic Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Lung Disease Therapeutic Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital Pharmacies grew percent to account for percent of the total market sales, and Retail Pharmacies grew percent.
This report studies and analyses global Lung Disease Therapeutic Drug status and future trends, helps the client to determine the Lung Disease Therapeutic Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Lung Disease Therapeutic Drug, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Lung Disease Therapeutic Drug market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Lung Disease Therapeutic Drug sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Lung Disease Therapeutic Drug sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Lung Disease Therapeutic Drug key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Lung Disease Therapeutic Drug key producing regions, capacity, production, and year over year growth
(6) Lung Disease Therapeutic Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
GSK
AstraZeneca
Boehringer Ingelheim
Novartis
Mylan
Vertex Pharmaceuticals
F. Hoffman La Roche
Teva Pharmaceuticals
Cipla
Fibrogen
Liminal Biosciences
PharmAkea Therapeutics
IQVIA
Market segment by Type, covers
Corticosteroids
Bronchodilator Medications
Mucolytics
Antimicrobial Medications
Others
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Lung Disease Therapeutic Drug product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Lung Disease Therapeutic Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Lung Disease Therapeutic Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Lung Disease Therapeutic Drug, percent & CAGR, 2018-2029
Chapter 5: Lung Disease Therapeutic Drug industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Lung Disease Therapeutic Drug Definition
1.2 Global Lung Disease Therapeutic Drug Market Size and Forecast
1.2.1 By Consumption Value, Global Lung Disease Therapeutic Drug Market Size，2018-2029
1.2.2 By Sales Quantity, Global Lung Disease Therapeutic Drug Market Size，2018-2029
1.2.3 Global Lung Disease Therapeutic Drug Average Selling Price (ASP)，2018-2029
1.3 China Lung Disease Therapeutic Drug Market Size and Forecast
1.3.1 By Consumption Value, China Lung Disease Therapeutic Drug Market Size，2018-2029
1.3.2 By Sales Quantity, China Lung Disease Therapeutic Drug Market Size，2018-2029
1.3.3 China Lung Disease Therapeutic Drug Average Selling Price (ASP)， 2018-2029
1.4 Share of China Lung Disease Therapeutic Drug Market with Respect to the Global Market
1.4.1 By Consumption Value, China Lung Disease Therapeutic Drug Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Lung Disease Therapeutic Drug Market Share in Global, 2018-2029
1.4.3 Lung Disease Therapeutic Drug Market Size: China VS Global, 2018-2029
1.5 Lung Disease Therapeutic Drug Market Dynamics
1.5.1 Lung Disease Therapeutic Drug Market Drivers
1.5.2 Lung Disease Therapeutic Drug Market Restraints
1.5.3 Lung Disease Therapeutic Drug Industry Trends
1.5.4 Lung Disease Therapeutic Drug Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Lung Disease Therapeutic Drug, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Lung Disease Therapeutic Drug, Global Market Share by Company, 2018-2023
2.3 Lung Disease Therapeutic Drug Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Lung Disease Therapeutic Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Lung Disease Therapeutic Drug Concentration Ratio
2.6 Global Lung Disease Therapeutic Drug Mergers & Acquisitions, Expansion Plans
2.7 Global Lung Disease Therapeutic Drug Manufacturers Product Type
2.8 Head Office and Lung Disease Therapeutic Drug Production Site of Key Manufacturer
2.9 Lung Disease Therapeutic Drug Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Lung Disease Therapeutic Drug, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Lung Disease Therapeutic Drug, China Market Share by Company, 2018-2023
3.3 China Lung Disease Therapeutic Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Lung Disease Therapeutic Drug Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Lung Disease Therapeutic Drug Capacity by Region
4.3 Global Lung Disease Therapeutic Drug Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Lung Disease Therapeutic Drug Production by Region, 2018-2029
4.5 Global Lung Disease Therapeutic Drug Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Lung Disease Therapeutic Drug Industry Chain
5.2 Lung Disease Therapeutic Drug Upstream Analysis
5.2.1 Lung Disease Therapeutic Drug Core Raw Materials
5.2.2 Main Manufacturers of Lung Disease Therapeutic Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Lung Disease Therapeutic Drug Production Mode
5.6 Lung Disease Therapeutic Drug Procurement Model
5.7 Lung Disease Therapeutic Drug Industry Sales Model and Sales Channels
5.7.1 Lung Disease Therapeutic Drug Sales Model
5.7.2 Lung Disease Therapeutic Drug Typical Distributors
6 Sights by Type
6.1 Lung Disease Therapeutic Drug Classification
6.1.1 Corticosteroids
6.1.2 Bronchodilator Medications
6.1.3 Mucolytics
6.1.4 Antimicrobial Medications
6.1.5 Others
6.2 By Type, Global Lung Disease Therapeutic Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Lung Disease Therapeutic Drug Consumption Value, 2018-2029
6.4 By Type, Global Lung Disease Therapeutic Drug Sales Quantity, 2018-2029
6.5 By Type, Global Lung Disease Therapeutic Drug Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Lung Disease Therapeutic Drug Segment by Application
7.1.1 Hospital Pharmacies
7.1.2 Retail Pharmacies
7.1.3 Online Pharmacies
7.2 By Application, Global Lung Disease Therapeutic Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Lung Disease Therapeutic Drug Consumption Value, 2018-2029
7.4 By Application, Global Lung Disease Therapeutic Drug Sales Quantity, 2018-2029
7.5 By Application, Global Lung Disease Therapeutic Drug Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Lung Disease Therapeutic Drug Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Lung Disease Therapeutic Drug Consumption Value, 2018-2029
8.3 By Region, Global Lung Disease Therapeutic Drug Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Lung Disease Therapeutic Drug & Forecasts, 2018-2029
8.4.2 By Country, North America Lung Disease Therapeutic Drug Market Size Market Share
8.5 Europe
8.5.1 Europe Lung Disease Therapeutic Drug Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Lung Disease Therapeutic Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Lung Disease Therapeutic Drug Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Lung Disease Therapeutic Drug Market Size Market Share
8.7 South America
8.7.1 South America Lung Disease Therapeutic Drug Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Lung Disease Therapeutic Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Lung Disease Therapeutic Drug Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Lung Disease Therapeutic Drug Consumption Value, 2018-2029
9.3 By Country, Global Lung Disease Therapeutic Drug Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Lung Disease Therapeutic Drug Market Size, 2018-2029
9.4.2 By Type, U.S. Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Lung Disease Therapeutic Drug Market Size, 2018-2029
9.5.2 By Type, Europe Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Lung Disease Therapeutic Drug Market Size, 2018-2029
9.6.2 By Type, China Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Lung Disease Therapeutic Drug Market Size, 2018-2029
9.7.2 By Type, Japan Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Lung Disease Therapeutic Drug Market Size, 2018-2029
9.8.2 By Type, South Korea Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Lung Disease Therapeutic Drug Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Lung Disease Therapeutic Drug Market Size, 2018-2029
9.10.2 By Type, India Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Lung Disease Therapeutic Drug Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 GSK
10.1.1 GSK Company Information, Head Office, Market Area, and Industry Position
10.1.2 GSK Lung Disease Therapeutic Drug Models, Specifications, and Application
10.1.3 GSK Lung Disease Therapeutic Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 GSK Company Profile and Main Business
10.1.5 GSK Recent Developments
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.2.2 AstraZeneca Lung Disease Therapeutic Drug Models, Specifications, and Application
10.2.3 AstraZeneca Lung Disease Therapeutic Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 AstraZeneca Company Profile and Main Business
10.2.5 AstraZeneca Recent Developments
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
10.3.2 Boehringer Ingelheim Lung Disease Therapeutic Drug Models, Specifications, and Application
10.3.3 Boehringer Ingelheim Lung Disease Therapeutic Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Boehringer Ingelheim Company Profile and Main Business
10.3.5 Boehringer Ingelheim Recent Developments
10.4 Novartis
10.4.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.4.2 Novartis Lung Disease Therapeutic Drug Models, Specifications, and Application
10.4.3 Novartis Lung Disease Therapeutic Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Novartis Company Profile and Main Business
10.4.5 Novartis Recent Developments
10.5 Mylan
10.5.1 Mylan Company Information, Head Office, Market Area, and Industry Position
10.5.2 Mylan Lung Disease Therapeutic Drug Models, Specifications, and Application
10.5.3 Mylan Lung Disease Therapeutic Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Mylan Company Profile and Main Business
10.5.5 Mylan Recent Developments
10.6 Vertex Pharmaceuticals
10.6.1 Vertex Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.6.2 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Models, Specifications, and Application
10.6.3 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Vertex Pharmaceuticals Company Profile and Main Business
10.6.5 Vertex Pharmaceuticals Recent Developments
10.7 F. Hoffman La Roche
10.7.1 F. Hoffman La Roche Company Information, Head Office, Market Area, and Industry Position
10.7.2 F. Hoffman La Roche Lung Disease Therapeutic Drug Models, Specifications, and Application
10.7.3 F. Hoffman La Roche Lung Disease Therapeutic Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 F. Hoffman La Roche Company Profile and Main Business
10.7.5 F. Hoffman La Roche Recent Developments
10.8 Teva Pharmaceuticals
10.8.1 Teva Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.8.2 Teva Pharmaceuticals Lung Disease Therapeutic Drug Models, Specifications, and Application
10.8.3 Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Teva Pharmaceuticals Company Profile and Main Business
10.8.5 Teva Pharmaceuticals Recent Developments
10.9 Cipla
10.9.1 Cipla Company Information, Head Office, Market Area, and Industry Position
10.9.2 Cipla Lung Disease Therapeutic Drug Models, Specifications, and Application
10.9.3 Cipla Lung Disease Therapeutic Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Cipla Company Profile and Main Business
10.9.5 Cipla Recent Developments
10.10 Fibrogen
10.10.1 Fibrogen Company Information, Head Office, Market Area, and Industry Position
10.10.2 Fibrogen Lung Disease Therapeutic Drug Models, Specifications, and Application
10.10.3 Fibrogen Lung Disease Therapeutic Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Fibrogen Company Profile and Main Business
10.10.5 Fibrogen Recent Developments
10.11 Liminal Biosciences
10.11.1 Liminal Biosciences Company Information, Head Office, Market Area, and Industry Position
10.11.2 Liminal Biosciences Lung Disease Therapeutic Drug Models, Specifications, and Application
10.11.3 Liminal Biosciences Lung Disease Therapeutic Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Liminal Biosciences Company Profile and Main Business
10.11.5 Liminal Biosciences Recent Developments
10.12 PharmAkea Therapeutics
10.12.1 PharmAkea Therapeutics Company Information, Head Office, Market Area, and Industry Position
10.12.2 PharmAkea Therapeutics Lung Disease Therapeutic Drug Models, Specifications, and Application
10.12.3 PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 PharmAkea Therapeutics Company Profile and Main Business
10.12.5 PharmAkea Therapeutics Recent Developments
10.13 IQVIA
10.13.1 IQVIA Company Information, Head Office, Market Area, and Industry Position
10.13.2 IQVIA Lung Disease Therapeutic Drug Models, Specifications, and Application
10.13.3 IQVIA Lung Disease Therapeutic Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 IQVIA Company Profile and Main Business
10.13.5 IQVIA Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Lung Disease Therapeutic Drug Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Lung Disease Therapeutic Drug Market Restraints
Table 3. Lung Disease Therapeutic Drug Market Trends
Table 4. Lung Disease Therapeutic Drug Industry Policy
Table 5. Global Lung Disease Therapeutic Drug Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Lung Disease Therapeutic Drug Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Lung Disease Therapeutic Drug Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Lung Disease Therapeutic Drug Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Lung Disease Therapeutic Drug Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Lung Disease Therapeutic Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Lung Disease Therapeutic Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global Lung Disease Therapeutic Drug Manufacturers Product Type
Table 13. Head Office and Lung Disease Therapeutic Drug Production Site of Key Manufacturer
Table 14. Lung Disease Therapeutic Drug Capacity of Major Manufacturers and Future Plan
Table 15. China Lung Disease Therapeutic Drug Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Lung Disease Therapeutic Drug Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Lung Disease Therapeutic Drug Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Lung Disease Therapeutic Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Lung Disease Therapeutic Drug Production by Region, 2018-2023, (K Units)
Table 20. Global Lung Disease Therapeutic Drug Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Lung Disease Therapeutic Drug Upstream (Raw Materials)
Table 22. Global Lung Disease Therapeutic Drug Typical Customers
Table 23. Lung Disease Therapeutic Drug Typical Distributors
Table 24. By Type, Global Lung Disease Therapeutic Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Lung Disease Therapeutic Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Lung Disease Therapeutic Drug Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Lung Disease Therapeutic Drug Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Lung Disease Therapeutic Drug Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Lung Disease Therapeutic Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Lung Disease Therapeutic Drug Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Lung Disease Therapeutic Drug Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Lung Disease Therapeutic Drug Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Lung Disease Therapeutic Drug Sales Quantity Market Share, 2018-2029
Table 34. GSK Company Information, Head Office, Market Area, and Industry Position
Table 35. GSK Lung Disease Therapeutic Drug Models, Specifications, and Application
Table 36. GSK Lung Disease Therapeutic Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. GSK Company Profile and Main Business
Table 38. GSK Recent Developments
Table 39. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 40. AstraZeneca Lung Disease Therapeutic Drug Models, Specifications, and Application
Table 41. AstraZeneca Lung Disease Therapeutic Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. AstraZeneca Company Profile and Main Business
Table 43. AstraZeneca Recent Developments
Table 44. Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
Table 45. Boehringer Ingelheim Lung Disease Therapeutic Drug Models, Specifications, and Application
Table 46. Boehringer Ingelheim Lung Disease Therapeutic Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Boehringer Ingelheim Company Profile and Main Business
Table 48. Boehringer Ingelheim Recent Developments
Table 49. Novartis Company Information, Head Office, Market Area, and Industry Position
Table 50. Novartis Lung Disease Therapeutic Drug Models, Specifications, and Application
Table 51. Novartis Lung Disease Therapeutic Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Novartis Company Profile and Main Business
Table 53. Novartis Recent Developments
Table 54. Mylan Company Information, Head Office, Market Area, and Industry Position
Table 55. Mylan Lung Disease Therapeutic Drug Models, Specifications, and Application
Table 56. Mylan Lung Disease Therapeutic Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Mylan Company Profile and Main Business
Table 58. Mylan Recent Developments
Table 59. Vertex Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 60. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Models, Specifications, and Application
Table 61. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Vertex Pharmaceuticals Company Profile and Main Business
Table 63. Vertex Pharmaceuticals Recent Developments
Table 64. F. Hoffman La Roche Company Information, Head Office, Market Area, and Industry Position
Table 65. F. Hoffman La Roche Lung Disease Therapeutic Drug Models, Specifications, and Application
Table 66. F. Hoffman La Roche Lung Disease Therapeutic Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. F. Hoffman La Roche Company Profile and Main Business
Table 68. F. Hoffman La Roche Recent Developments
Table 69. Teva Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 70. Teva Pharmaceuticals Lung Disease Therapeutic Drug Models, Specifications, and Application
Table 71. Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Teva Pharmaceuticals Company Profile and Main Business
Table 73. Teva Pharmaceuticals Recent Developments
Table 74. Cipla Company Information, Head Office, Market Area, and Industry Position
Table 75. Cipla Lung Disease Therapeutic Drug Models, Specifications, and Application
Table 76. Cipla Lung Disease Therapeutic Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Cipla Company Profile and Main Business
Table 78. Cipla Recent Developments
Table 79. Fibrogen Company Information, Head Office, Market Area, and Industry Position
Table 80. Fibrogen Lung Disease Therapeutic Drug Models, Specifications, and Application
Table 81. Fibrogen Lung Disease Therapeutic Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Fibrogen Company Profile and Main Business
Table 83. Fibrogen Recent Developments
Table 84. Liminal Biosciences Company Information, Head Office, Market Area, and Industry Position
Table 85. Liminal Biosciences Lung Disease Therapeutic Drug Models, Specifications, and Application
Table 86. Liminal Biosciences Lung Disease Therapeutic Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Liminal Biosciences Company Profile and Main Business
Table 88. Liminal Biosciences Recent Developments
Table 89. PharmAkea Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 90. PharmAkea Therapeutics Lung Disease Therapeutic Drug Models, Specifications, and Application
Table 91. PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. PharmAkea Therapeutics Company Profile and Main Business
Table 93. PharmAkea Therapeutics Recent Developments
Table 94. IQVIA Company Information, Head Office, Market Area, and Industry Position
Table 95. IQVIA Lung Disease Therapeutic Drug Models, Specifications, and Application
Table 96. IQVIA Lung Disease Therapeutic Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. IQVIA Company Profile and Main Business
Table 98. IQVIA Recent Developments
List of Figures
Figure 1. Lung Disease Therapeutic Drug Picture
Figure 2. Global Lung Disease Therapeutic Drug Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Lung Disease Therapeutic Drug Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Lung Disease Therapeutic Drug Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Lung Disease Therapeutic Drug Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Lung Disease Therapeutic Drug Sales Quantity (K Units) & (2018-2029)
Figure 7. China Lung Disease Therapeutic Drug Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Lung Disease Therapeutic Drug Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Lung Disease Therapeutic Drug Market Share of Global, 2018-2029
Figure 10. Global Lung Disease Therapeutic Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Lung Disease Therapeutic Drug Key Participants, Market Share, 2022
Figure 12. Global Lung Disease Therapeutic Drug Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Lung Disease Therapeutic Drug Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Lung Disease Therapeutic Drug Production Market Share & Forecast by Region, 2018-2029
Figure 15. Lung Disease Therapeutic Drug Industry Chain
Figure 16. Lung Disease Therapeutic Drug Procurement Model
Figure 17. Lung Disease Therapeutic Drug Sales Model
Figure 18. Lung Disease Therapeutic Drug Sales Channels, Direct Sales, and Distribution
Figure 19. Corticosteroids
Figure 20. Bronchodilator Medications
Figure 21. Mucolytics
Figure 22. Antimicrobial Medications
Figure 23. Others
Figure 24. By Type, Global Lung Disease Therapeutic Drug Consumption Value, 2018-2029, US$ Million
Figure 25. By Type, Global Lung Disease Therapeutic Drug Consumption Value Market Share, 2018-2029
Figure 26. By Type, Global Lung Disease Therapeutic Drug Sales Quantity, 2018-2029, (K Units)
Figure 27. By Type, Global Lung Disease Therapeutic Drug Sales Quantity Market Share, 2018-2029
Figure 28. By Type, Global Lung Disease Therapeutic Drug Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 29. Hospital Pharmacies
Figure 30. Retail Pharmacies
Figure 31. Online Pharmacies
Figure 32. By Application, Global Lung Disease Therapeutic Drug Consumption Value, 2018-2029, US$ Million
Figure 33. By Application, Global Lung Disease Therapeutic Drug Consumption Value Market Share, 2018-2029
Figure 34. By Application, Global Lung Disease Therapeutic Drug Sales Quantity, 2018-2029, (K Units)
Figure 35. By Application, Global Lung Disease Therapeutic Drug Sales Quantity Market Share, 2018-2029
Figure 36. By Application, Global Lung Disease Therapeutic Drug Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 37. By Region, Global Lung Disease Therapeutic Drug Consumption Value Market Share, 2018-2029
Figure 38. By Region, Global Lung Disease Therapeutic Drug Sales Quantity Market Share, 2018-2029
Figure 39. North America Lung Disease Therapeutic Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America Lung Disease Therapeutic Drug Consumption Value Market Share, 2022
Figure 41. Europe Lung Disease Therapeutic Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe Lung Disease Therapeutic Drug Consumption Value Market Share, 2022
Figure 43. Asia Pacific Lung Disease Therapeutic Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific Lung Disease Therapeutic Drug Consumption Value Market Share, 2022
Figure 45. South America Lung Disease Therapeutic Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America Lung Disease Therapeutic Drug Consumption Value Market Share, 2022
Figure 47. Middle East & Africa Lung Disease Therapeutic Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. Lung Disease Therapeutic Drug Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, U.S. Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, U.S. Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 51. Europe Lung Disease Therapeutic Drug Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, Europe Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, Europe Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 54. China Lung Disease Therapeutic Drug Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, China Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, China Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 57. Japan Lung Disease Therapeutic Drug Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, Japan Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, Japan Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 60. South Korea Lung Disease Therapeutic Drug Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, South Korea Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, South Korea Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 63. Southeast Asia Lung Disease Therapeutic Drug Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, Southeast Asia Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, Southeast Asia Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 66. India Lung Disease Therapeutic Drug Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, India Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, India Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 69. Middle East & Africa Lung Disease Therapeutic Drug Sales Quantity, 2018-2029, (K Units)
Figure 70. By Type, Middle East & Africa Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 71. By Application, Middle East & Africa Lung Disease Therapeutic Drug Sales Quantity Market Share, 2022 VS 2029
Figure 72. Research Methodology
Figure 73. Breakdown of Primary Interviews
Figure 74. Bottom-up and Top-down Approaches
Figure 75. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|